Weave Bio, the leader in AI-native regulatory automation, today announced the launch of HAQ Manager, a breakthrough capability that applies artificial intelligence (AI) and workflow automation to ...

Takeda (TSE:4502/NYSE:TAK) announced the completion of the 7-year pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial evaluating its dengue vaccine, QDENGA®?(Dengue ...

DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specializes in ...

The global psoriasis treatment market is projected to expand at a compound annual growth rate (CAGR) of 8.5% by 2026. Key factors fueling this growth include the rising prevalence of psoriasis, ...

Data published in the American Journal of Gastroenterology showed rapid and sustained relief of nighttime gastroesophageal reflux disease (GERD) ...

Incyte (Nasdaq:INCY) today reported financial results for the third quarter of 2025 and provided a business update.

SAP SE (SAP) reported third-quarter 2025 non-IFRS earnings of €1.59 ($1.86) per share, climbing 29% from the year-ago quarter ...

The results bolster confidence in Takeda’s two-dose regimen, especially as countries grapple with record dengue outbreaks ...

Takeda Pharmaceutical (TSE:4502) shares have been moving in line with broader market shifts, drawing attention as investors consider the company’s current valuation. While recent trading has seen ...

Office: Takeda rare drug manufacturing facility. (Photo c/o Takeda Pharmaceuticals) Tokyo-based Takeda Pharmaceuticals Co. this month completed a $170 million expansion and renovation project on its ...

Takeda tightened its pipeline in the third quarter. Innovent Biologics reported a head-to-head win against semaglutide in a Chinese phase 3 trial. | Takeda tightened its pipeline in the third quarter.

Oct 14 (Reuters) - U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical (4502.T), opens new tab, deepening their ...